Antidrug antibodies did not appear to negatively affect outcomes in patients with inflammatory bowel disease after initiation of subcutaneous infliximab following a “drug holiday,” according to a ...
IntroductionWhen you receive a call in the emergency room or on the ward during an on-call shift that "there is a patient ...
These GLP-1 injections have been recalled nationwide. Here's the affected medication and reasoning behind the recall.
If your pain is caused by an underlying inflammatory condition, a doctor—often a rheumatologist—will likely prescribe ...
Absence of branched N-glycans on γδ T cells acts as a peripheral signal that amplifies a type 3/IL-17A response in ...
Subcutaneous mosunetuzumab replaced the IV infusion for patients with R/R LBCL; 57.5% had mostly mild injection-site ...
Eliminating anxiety and burden regarding children's illnesses—1,000 Prescriptions Written by a Pediatric Specialist—From ...
The FDA has approved Weltruza, the first once-monthly, subcutaneous, long-acting injectable form of olanzapine for adults ...
New Phase 3 AFFIRM data show higher rates of clinical and endoscopic response in Crohn's disease patients treated with subcutaneous SKYRIZI versus placebo across all efficacy endpoints ...
New clinical data at the HFSA ASM 2026 showcases the pharmacokinetic and pharmacodynamic performance of Furoscix ReadyFlow, ...
It took Christa Pike nearly a week to regain consciousness after the Tennessee Department of Corrections failed to kill her with two doses of the barbiturate pentobarbital, a drug used to put animals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results